Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations
Clinical trial NCT02628613 · COMPLETED
Trial details
- NCT number
- NCT02628613
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2019-02-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.